secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001493152-26-014822
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio signs enrollment deal with Iterative Health, issues $3M stock to affiliate
--------------------------------------------------------------------------------

- Entered MSA with Iterative Health to assist with patient enrollment for Phase 2 study of PALI-2108 in ulcerative colitis.
- Issued 1,536,885 shares at $1.952/share (5-day VWAP) for total $3.0 million to an affiliate of Iterative Health.
- Funds support accelerated enrollment; shares sold in private placement exempt from registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315226014822/0001493152-26-014822-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315226014822/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-014822

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer